Sweden's Svante Pääbo wins Nobel prize in medicine for work on evolution

Screen shows the winner of the 2022 Nobel Prize in Physiology or Medicine, Sweden's Svante Paabo, during a news conference at the Karolinska Institute in Stockholm, Sweden, on October 3, 2022. JONATHAN NACKSTRAND/AFP via Getty Images

Stockholm — This year's Nobel Prize in physiology or medicine has been awarded to Swedish scientist Svante Pääbo for his discoveries on human evolution.

Thomas Perlmann, secretary of the Nobel Committee, announced the winner Monday at the Karolinska Institute in Stockholm, Sweden.

Paabo, 67, has spearheaded research comparing the genome of modern humans and our closest extinct relatives, the Neanderthals and Denisovans, showing that there was mixing between the species.

"By revealing genetic differences that distinguish all living humans from extinct hominins, his discoveries provide the basis for exploring what makes us uniquely human", the Nobel committee said.

"This ancient flow of genes to present-day humans has physiological relevance today, for example affecting how our immune system reacts to infections," the panel said.

The medicine prize kicked off a week of Nobel Prize announcements. It continues Tuesday with the physics prize, with chemistry on Wednesday and literature on Thursday. The 2022 Nobel Peace Prize will be announced on Friday and the economics award on Oct. 10.

Last year's recipients were David Julius and Ardem Patapoutian for their discoveries into how the human body perceives temperature and touch.

The prizes carry a cash award of 10 million Swedish kronor (nearly $900,000) and will be handed out on Dec. 10. The money comes from a bequest left by the prize's creator, Swedish inventor Alfred Nobel, who died in 1895.

f

We and our partners use cookies to understand how you use our site, improve your experience and serve you personalized content and advertising. Read about how we use cookies in our cookie policy and how you can control them by clicking Manage Settings. By continuing to use this site, you accept these cookies.